"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","description.1","data_processing","platform_id","contact_name","contact_email","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","supplementary_file.1","data_row_count"
"GSM773124","Cancer Urothelia-1","GSM773124","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000001","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773124/GSM773124.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773124/GSM773124.CHP.gz","54675"
"GSM773125","Cancer Urothelia-2","GSM773125","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000002","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773125/GSM773125.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773125/GSM773125.CHP.gz","54675"
"GSM773126","Cancer Urothelia-3","GSM773126","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000003","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773126/GSM773126.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773126/GSM773126.CHP.gz","54675"
"GSM773127","Cancer Urothelia-4","GSM773127","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000004","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773127/GSM773127.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773127/GSM773127.CHP.gz","54675"
"GSM773128","Cancer Urothelia-5","GSM773128","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000005","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773128/GSM773128.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773128/GSM773128.CHP.gz","54675"
"GSM773129","Cancer Urothelia-6","GSM773129","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000006","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773129/GSM773129.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773129/GSM773129.CHP.gz","54675"
"GSM773130","Cancer Urothelia-7","GSM773130","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000007","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773130/GSM773130.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773130/GSM773130.CHP.gz","54675"
"GSM773131","Cancer Urothelia-8","GSM773131","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000008","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773131/GSM773131.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773131/GSM773131.CHP.gz","54675"
"GSM773132","Cancer Urothelia-9","GSM773132","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000009","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773132/GSM773132.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773132/GSM773132.CHP.gz","54675"
"GSM773133","Cancer Urothelia-10","GSM773133","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000010","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773133/GSM773133.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773133/GSM773133.CHP.gz","54675"
"GSM773134","Cancer Urothelia-11","GSM773134","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000011","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773134/GSM773134.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773134/GSM773134.CHP.gz","54675"
"GSM773135","Cancer Urothelia-12","GSM773135","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000012","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773135/GSM773135.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773135/GSM773135.CHP.gz","54675"
"GSM773136","Cancer Urothelia-13","GSM773136","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000013","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773136/GSM773136.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773136/GSM773136.CHP.gz","54675"
"GSM773137","Cancer Urothelia-14","GSM773137","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000014","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773137/GSM773137.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773137/GSM773137.CHP.gz","54675"
"GSM773138","Cancer Urothelia-15","GSM773138","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000015","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773138/GSM773138.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773138/GSM773138.CHP.gz","54675"
"GSM773139","Cancer Urothelia-16","GSM773139","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000016","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773139/GSM773139.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773139/GSM773139.CHP.gz","54675"
"GSM773140","Cancer Urothelia-17","GSM773140","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000017","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773140/GSM773140.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773140/GSM773140.CHP.gz","54675"
"GSM773141","Cancer Urothelia-18","GSM773141","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000018","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773141/GSM773141.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773141/GSM773141.CHP.gz","54675"
"GSM773142","Cancer Urothelia-19","GSM773142","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000019","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773142/GSM773142.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773142/GSM773142.CHP.gz","54675"
"GSM773143","Cancer Urothelia-20","GSM773143","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000020","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773143/GSM773143.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773143/GSM773143.CHP.gz","54675"
"GSM773144","Cancer Urothelia-21","GSM773144","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000021","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773144/GSM773144.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773144/GSM773144.CHP.gz","54675"
"GSM773145","Cancer Urothelia-22","GSM773145","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000022","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773145/GSM773145.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773145/GSM773145.CHP.gz","54675"
"GSM773146","Cancer Urothelia-23","GSM773146","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000023","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773146/GSM773146.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773146/GSM773146.CHP.gz","54675"
"GSM773147","Cancer Urothelia-24","GSM773147","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000024","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773147/GSM773147.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773147/GSM773147.CHP.gz","54675"
"GSM773148","Cancer Urothelia-25","GSM773148","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000025","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773148/GSM773148.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773148/GSM773148.CHP.gz","54675"
"GSM773149","Cancer Urothelia-26","GSM773149","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000026","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773149/GSM773149.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773149/GSM773149.CHP.gz","54675"
"GSM773150","Cancer Urothelia-27","GSM773150","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000027","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773150/GSM773150.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773150/GSM773150.CHP.gz","54675"
"GSM773151","Cancer Urothelia-28","GSM773151","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000028","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773151/GSM773151.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773151/GSM773151.CHP.gz","54675"
"GSM773152","Cancer Urothelia-29","GSM773152","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000029","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773152/GSM773152.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773152/GSM773152.CHP.gz","54675"
"GSM773153","Cancer Urothelia-30","GSM773153","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000030","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773153/GSM773153.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773153/GSM773153.CHP.gz","54675"
"GSM773154","Cancer Urothelia-31","GSM773154","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000031","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773154/GSM773154.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773154/GSM773154.CHP.gz","54675"
"GSM773155","Cancer Urothelia-32","GSM773155","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000032","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773155/GSM773155.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773155/GSM773155.CHP.gz","54675"
"GSM773156","Cancer Urothelia-33","GSM773156","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000033","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773156/GSM773156.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773156/GSM773156.CHP.gz","54675"
"GSM773157","Cancer Urothelia-34","GSM773157","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000034","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773157/GSM773157.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773157/GSM773157.CHP.gz","54675"
"GSM773158","Cancer Urothelia-35","GSM773158","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000035","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773158/GSM773158.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773158/GSM773158.CHP.gz","54675"
"GSM773159","Cancer Urothelia-36","GSM773159","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000036","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773159/GSM773159.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773159/GSM773159.CHP.gz","54675"
"GSM773160","Cancer Urothelia-37","GSM773160","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000037","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773160/GSM773160.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773160/GSM773160.CHP.gz","54675"
"GSM773161","Cancer Urothelia-38","GSM773161","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000038","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773161/GSM773161.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773161/GSM773161.CHP.gz","54675"
"GSM773162","Cancer Urothelia-39","GSM773162","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000039","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773162/GSM773162.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773162/GSM773162.CHP.gz","54675"
"GSM773163","Cancer Urothelia-40","GSM773163","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000040","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773163/GSM773163.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773163/GSM773163.CHP.gz","54675"
"GSM773164","Cancer Urothelia-41","GSM773164","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000041","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773164/GSM773164.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773164/GSM773164.CHP.gz","54675"
"GSM773165","Cancer Urothelia-42","GSM773165","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000042","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773165/GSM773165.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773165/GSM773165.CHP.gz","54675"
"GSM773166","Cancer Urothelia-43","GSM773166","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000043","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773166/GSM773166.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773166/GSM773166.CHP.gz","54675"
"GSM773167","Cancer Urothelia-44","GSM773167","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000044","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773167/GSM773167.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773167/GSM773167.CHP.gz","54675"
"GSM773168","Cancer Urothelia-45","GSM773168","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000045","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773168/GSM773168.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773168/GSM773168.CHP.gz","54675"
"GSM773169","Cancer Urothelia-46","GSM773169","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000046","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773169/GSM773169.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773169/GSM773169.CHP.gz","54675"
"GSM773170","Cancer Urothelia-47","GSM773170","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000047","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773170/GSM773170.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773170/GSM773170.CHP.gz","54675"
"GSM773171","Cancer Urothelia-48","GSM773171","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000048","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773171/GSM773171.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773171/GSM773171.CHP.gz","54675"
"GSM773172","Cancer Urothelia-49","GSM773172","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000049","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773172/GSM773172.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773172/GSM773172.CHP.gz","54675"
"GSM773173","Cancer Urothelia-50","GSM773173","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000050","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773173/GSM773173.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773173/GSM773173.CHP.gz","54675"
"GSM773174","Cancer Urothelia-51","GSM773174","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000051","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773174/GSM773174.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773174/GSM773174.CHP.gz","54675"
"GSM773175","Cancer Urothelia-52","GSM773175","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, cancer","Homo sapiens","cell type: urothelial cancer cells","disease status: bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","C-000052","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773175/GSM773175.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773175/GSM773175.CHP.gz","54675"
"GSM773176","Non-Cancer Urothelia-1","GSM773176","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000001","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773176/GSM773176.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773176/GSM773176.CHP.gz","54675"
"GSM773177","Non-Cancer Urothelia-2","GSM773177","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000002","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773177/GSM773177.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773177/GSM773177.CHP.gz","54675"
"GSM773178","Non-Cancer Urothelia-3","GSM773178","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000003","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773178/GSM773178.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773178/GSM773178.CHP.gz","54675"
"GSM773179","Non-Cancer Urothelia-4","GSM773179","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000004","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773179/GSM773179.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773179/GSM773179.CHP.gz","54675"
"GSM773180","Non-Cancer Urothelia-5","GSM773180","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000005","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773180/GSM773180.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773180/GSM773180.CHP.gz","54675"
"GSM773181","Non-Cancer Urothelia-6","GSM773181","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000006","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773181/GSM773181.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773181/GSM773181.CHP.gz","54675"
"GSM773182","Non-Cancer Urothelia-7","GSM773182","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000007","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773182/GSM773182.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773182/GSM773182.CHP.gz","54675"
"GSM773183","Non-Cancer Urothelia-8","GSM773183","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000008","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773183/GSM773183.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773183/GSM773183.CHP.gz","54675"
"GSM773184","Non-Cancer Urothelia-9","GSM773184","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000009","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773184/GSM773184.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773184/GSM773184.CHP.gz","54675"
"GSM773185","Non-Cancer Urothelia-10","GSM773185","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000010","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773185/GSM773185.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773185/GSM773185.CHP.gz","54675"
"GSM773186","Non-Cancer Urothelia-11","GSM773186","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000011","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773186/GSM773186.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773186/GSM773186.CHP.gz","54675"
"GSM773187","Non-Cancer Urothelia-12","GSM773187","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000012","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773187/GSM773187.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773187/GSM773187.CHP.gz","54675"
"GSM773188","Non-Cancer Urothelia-13","GSM773188","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000013","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773188/GSM773188.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773188/GSM773188.CHP.gz","54675"
"GSM773189","Non-Cancer Urothelia-14","GSM773189","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000014","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773189/GSM773189.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773189/GSM773189.CHP.gz","54675"
"GSM773190","Non-Cancer Urothelia-15","GSM773190","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000015","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773190/GSM773190.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773190/GSM773190.CHP.gz","54675"
"GSM773191","Non-Cancer Urothelia-16","GSM773191","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000016","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773191/GSM773191.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773191/GSM773191.CHP.gz","54675"
"GSM773192","Non-Cancer Urothelia-17","GSM773192","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000017","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773192/GSM773192.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773192/GSM773192.CHP.gz","54675"
"GSM773193","Non-Cancer Urothelia-18","GSM773193","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000018","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773193/GSM773193.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773193/GSM773193.CHP.gz","54675"
"GSM773194","Non-Cancer Urothelia-19","GSM773194","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000019","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773194/GSM773194.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773194/GSM773194.CHP.gz","54675"
"GSM773195","Non-Cancer Urothelia-20","GSM773195","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000020","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773195/GSM773195.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773195/GSM773195.CHP.gz","54675"
"GSM773196","Non-Cancer Urothelia-21","GSM773196","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000021","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773196/GSM773196.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773196/GSM773196.CHP.gz","54675"
"GSM773197","Non-Cancer Urothelia-22","GSM773197","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000022","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773197/GSM773197.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773197/GSM773197.CHP.gz","54675"
"GSM773198","Non-Cancer Urothelia-23","GSM773198","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000023","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773198/GSM773198.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773198/GSM773198.CHP.gz","54675"
"GSM773199","Non-Cancer Urothelia-24","GSM773199","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000024","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773199/GSM773199.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773199/GSM773199.CHP.gz","54675"
"GSM773200","Non-Cancer Urothelia-25","GSM773200","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000025","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773200/GSM773200.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773200/GSM773200.CHP.gz","54675"
"GSM773201","Non-Cancer Urothelia-26","GSM773201","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000026","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773201/GSM773201.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773201/GSM773201.CHP.gz","54675"
"GSM773202","Non-Cancer Urothelia-27","GSM773202","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000027","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773202/GSM773202.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773202/GSM773202.CHP.gz","54675"
"GSM773203","Non-Cancer Urothelia-28","GSM773203","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000028","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773203/GSM773203.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773203/GSM773203.CHP.gz","54675"
"GSM773204","Non-Cancer Urothelia-29","GSM773204","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000029","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773204/GSM773204.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773204/GSM773204.CHP.gz","54675"
"GSM773205","Non-Cancer Urothelia-30","GSM773205","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000030","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773205/GSM773205.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773205/GSM773205.CHP.gz","54675"
"GSM773206","Non-Cancer Urothelia-31","GSM773206","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000031","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773206/GSM773206.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773206/GSM773206.CHP.gz","54675"
"GSM773207","Non-Cancer Urothelia-32","GSM773207","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000032","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773207/GSM773207.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773207/GSM773207.CHP.gz","54675"
"GSM773208","Non-Cancer Urothelia-33","GSM773208","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000033","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773208/GSM773208.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773208/GSM773208.CHP.gz","54675"
"GSM773209","Non-Cancer Urothelia-34","GSM773209","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000034","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773209/GSM773209.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773209/GSM773209.CHP.gz","54675"
"GSM773210","Non-Cancer Urothelia-35","GSM773210","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000035","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773210/GSM773210.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773210/GSM773210.CHP.gz","54675"
"GSM773211","Non-Cancer Urothelia-36","GSM773211","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000036","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773211/GSM773211.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773211/GSM773211.CHP.gz","54675"
"GSM773212","Non-Cancer Urothelia-37","GSM773212","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000037","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773212/GSM773212.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773212/GSM773212.CHP.gz","54675"
"GSM773213","Non-Cancer Urothelia-38","GSM773213","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000038","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773213/GSM773213.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773213/GSM773213.CHP.gz","54675"
"GSM773214","Non-Cancer Urothelia-39","GSM773214","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000039","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773214/GSM773214.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773214/GSM773214.CHP.gz","54675"
"GSM773215","Non-Cancer Urothelia-40","GSM773215","Public on Jan 08 2013","Aug 03 2011","Jan 08 2013","RNA","1","Bladder barbotage, non-cancer","Homo sapiens","cell type: non-cancer urothelial cells","disease status: no bladder cancer","total RNA","Total RNA was  extracted from urothelial cells using the Qiagen RNeasy protocol.","biotin","Preparation of labeled cRNA was performed according to the Affymetrix Two-Cycle Target Labeling Assay.","9606","Fragmented, biotinylated cRNA was hybridized to Affymetrix Human Genome U133 Plus 2.0 microarrays. The Affymetrix GeneChip system used  includes an Affymetrix 450 fluidics station, 3000 scanner, hybridization oven and GeneChip Operating Software.","GeneChips were scanned using the Hewlett-Packard GeneArray Scanner 3000.","NC-000040","Gene expression data from human urothelial cells in urine sediment.","The data was normalized using the MAS5 algorithm provided in Expression Console 1.1 of Affymetrix. The output are positive values.","GPL570","Virginia,,Urquidi","virginia.urquidi@orlandohealth.com","CRI","MD Anderson Cancer Center Orlando","6900 Lake Nona Blvd","Orlando","FL","32827","USA","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773215/GSM773215.CEL.gz","ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM773nnn/GSM773215/GSM773215.CHP.gz","54675"
